Spencer G. Feldman

Spencer G. Feldman is a securities and capital markets lawyer widely known for his experience in public securities offerings and media and technology transactions.

Spencer has more than 30 years of experience practicing corporate and securities law and concentrates his practice in the areas of initial public offerings, follow-on offerings, shelf takedowns, confidentially marketed offerings, registered directs, PIPEs and other private financings, rights offerings, reverse public offerings, and mergers & acquisitions with public companies, with an emphasis on representing computer, Internet, media, life sciences and other technology-driven companies, and the banks, financial institutions and other institutional investors that provide capital to these companies. More recently, he has been involved in several Regulation A+ public offerings, Rule 506(c) publicly-solicited placements and Section 4(a)(6) crowdfunding transactions.

Spencer serves as counsel to a number of emerging technology business ventures, including companies involved in consumer financial technology, social media sponsorships, online video distribution, electric vehicle charging stations, regenerative medical clinics, facial animation software, and biopharmaceutical vaccines and diagnostics.

Spencer previously served as a member of the Board of Directors of Tapinator, Inc., a publicly-traded developer and publisher of category leading apps for mobile platforms.

Spencer was a member of the 2016 and 2017 Capital Markets Law360 editorial advisory board, and was also a 2016 member. He was a member of the editorial board of the Journal of Commercial Biotechnology, a leading international publication for bioscience business professionals, until 2020.  He participated as a panelist discussing “Registered Offerings – Post JOBS Act Implementation" and served as the moderator of the Smaller Reporting Companies Breakout Group at the 2015 SEC Government – Business Forum on Small Business Capital Formation, U.S. Securities and Exchange Commission, Washington, D.C., November 19, 2015.  He also participated on the panel, "Uplisting to an Exchange: Criteria and Strategies for Emerging Growth Companies," at The Growth Capital Summit 2015: Legal and Regulatory Update on Emerging Growth Company Finance, The National Press Club, Washington, D.C., November 18, 2015.

Spencer is a frequent contributor to the firm’s Securities Law Blog. His recent article on the SEC’s proposal to permit capital-raising activities by unregistered finders was published in the Harvard Law School Forum on Corporate Governance.

Prior to joining Olshan, Spencer was a shareholder at Greenberg Traurig, LLP in its corporate & securities practice for more than 20 years.

Professional & Community Affiliations

• Member, Capital Markets Law360 Editorial Board, 2016-2017
• Member, American Bar Association
• Member, Federal Regulation of Securities Committee
  Member, Small Business Issuers Subcommittee
  Member, Securities Regulation Subcommittee of the Middle Market and Small Business Committee
• Participant, SEC Government-Business Forum on Small Business Capital Formation
• Member, New York State Bar Association’s Business Law Section
• Member, Advisory Board, Albany Law School's Center for Law and Innovation
• Member of Drafting Committee, Federal Regulation of Securities Committee of the ABA Business Law Section, Response to SEC’s Request for Public Comments on the Crowdfunding Securities Exemption under Exchange Act Section 12(g)(6)

• Represented Aegis Capital Corp., as sole bookrunner and representative of the several underwriters, in NanoViricides, Inc.’s (NYSE American: NNVC) $8.65 million follow-on equity public offering of 2,875,000 shares of common stock, including the underwriters’ full exercise of their 375,000 over-allotment option. NanoViricides is a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform. NanoViricides believes this financing provides valuable capital to help the company advance its drug pipeline into human clinical trials. NanoViricides anticipates filing an IND with the US FDA to advance NV-HHV-101 into human clinical trials for topical dermal treatment of the shingles rash as the initial indication.
• Represented IMAC Holdings, Inc. in the underwritten initial public offering of IMAC’s shares of common stock and warrants to purchase common stock, at a public offering price of $5.125 per unit.  IMAC owns and manages outpatient medical clinics throughout the Midwest that provide regenerative, orthopedic and minimally invasive procedures and therapies centered around treating sports injuries. IMAC has partnered with several active and former professional athletes, opening two Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, and a Tony Delk IMAC Regeneration Center. Dawson James Securities, Inc. acted as the book running manager and Axiom Capital Management, Inc. and The Benchmark Company LLC acted as co-managers for the offering. IMAC’s shares and warrants are trading on The NASDAQ Capital Market under the ticker symbols “IMAC” and IMACW.”
• Represented Legacy Housing Corporation in the initial public offering of an aggregate of 4,000,000 shares of its common stock at a public offering price of $12.00 per share. Legacy Housing is the fourth largest producer of manufactured homes in the United States and a recognized leader and innovator in the manufactured housing industry. Shares of the company are trading on The NASDAQ Global Select Market under the symbol “LEGH.” The offering was made through an underwriting group led by B. Riley FBR, Inc., Oak Ridge Financial and National Securities Corporation.
• Represented Cemtrex, Inc. (NasdaqCM: CETX), a global diversified industrial company, in its acquisition of 7,284,824 shares of common stock and a warrant to purchase an additional 1,500,000 shares of common stock of Vicon Industries, Inc. (NYSE American: VII), a producer of video management systems for use in security, surveillance, safety and communication applications, from former Vicon Industries shareholder NIL Funding Corporation, pursuant to the terms of a Securities Purchase Agreement. Cemtrex's purchase of the Vicon Industries common stock and warrant resulted in its beneficial ownership of approximately 46% of the outstanding shares of common stock of Vicon Industries. Cemtrex purchased the shares of common stock and warrant of Vicon Industries in exchange for 1,012,625 shares of Cemtrex common stock. Under the Securities Purchase Agreement, Cemtrex agreed to file a registration statement with the Securities and Exchanges Commission and to use its commercially reasonable efforts to cause such registration statement to become effective with respect to the resale of the Cemtrex common stock. Following the closing of the transaction, Saagar Govil, Cemtrex's Chairman and Chief Executive Officer, and Aron Govil, Cemtrex's Executive Director, joined the Vicon Industries Board of Directors and Saagar Govil assumed the position of Chief Executive Officer of Vicon Industries.
• Represented the National Association of Professional Women (NAPW), one of the largest, most-recognized networking organizations of professional women in the country, in its merger with the Professional Diversity Network, Inc. (NASDAQ: IPDN), a Chicago-based operator of online professional networking communities dedicated to serving diverse professionals and employers seeking to hire diverse talent. Pursuant to the parties’ Merger Agreement entered into in July 2014, and then approved by PDN’s stockholders, NAPW’s sole shareholder, Matthew B. Proman, and senior executive officers, including Star Jones, NAPW’s President and National Spokeswoman, received a total of 6,309,845 shares of PDN common stock at closing, equal to 50% of the PDN’s outstanding shares, and Mr. Proman also received other consideration including cash and a seller note. At closing, the combined companies have a market capitalization of $70.0 million. Following the merger, Matthew B. Proman and Star Jones will join PDN’s Board of Directors, along with NAPW’s director nominees Randi Zuckerberg and Donna Brazile, and Ms. Jones will become PDN’s President and Mr. Proman will become its Executive Vice President and Chief Operating Officer.
• Represented Maxim Group LLC, a leading investment banking firm for middle-market and emerging growth public companies, as the sole book running manager and lead underwriter of the confidentially marketed public offering of shares of common stock and warrants for Quest Resource Holding Corporation (NASDAQ: QRHC), a Frisco, Texas based provider of comprehensive recycling and resource management solution and of social media and online data platforms for consumers and businesses concerning proper waste disposal management, valued at $18.0 million. The net proceeds of the offering are being used by Quest Resource to retire debt and for general corporate purposes. The shares of common stock and warrants in the offering were issued pursuant to Quest Resource’s shelf registration statement on Form S-3 and its prospectus supplement filed with the SEC. Maxim Group has a 45-day over-allotment option to purchase $1.4 million of additional shares and warrants.

Press Releases